Direct Reprogramming Factors

   

Transdifferentiation (TD) is the direct conversion of one cell type to another. This reprogramming method provides a fast route for creating novel cell types and manufacturing functional tissues. TD enables the generation of patient-specific cell types without the risk of creating potentially tumorigenic induced pluripotent stem cells before differentiation. The TD-Consortium, offered by SBI, includes collections of transcription factors and microRNA precursors built in constitutive or inducible vector formats to allow you to harness the TD technology and advance regenerative medicine research.

Recent History of Transdifferentiation